Sangamo Therapeutics
SGMO
#10604
Rank
NZ$55.05 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-85.29%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -NZ$34.05 Million

According to Sangamo Therapeutics 's latest financial reports the company has -NZ$34.05 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$0.13 B-71.79%
2022-12-31$NZ$0.46 B-15.46%
2021-12-31$NZ$0.54 B-20.28%
2020-12-31$NZ$0.68 B7.28%
2019-12-31$NZ$0.64 B17.36%
2018-12-31$NZ$0.54 B106.94%
2017-12-31$NZ$0.26 B34.56%
2016-12-31$NZ$0.19 B-30.07%
2015-12-31$NZ$0.28 B6.62%
2014-12-31$NZ$0.26 B78.06%
2013-12-31$NZ$0.14 B87.75%
2012-12-31$NZ$78.88 M-23.17%
2011-12-31$NZ$0.10 B41.68%
2010-12-31$NZ$72.46 M-26.68%
2009-12-31$NZ$98.82 M3.53%
2008-12-31$NZ$95.45 M1.38%
2007-12-31$NZ$94.15 M36.19%
2006-12-31$NZ$69.13 M24.96%
2005-12-31$NZ$55.32 M21.93%
2004-12-31$NZ$45.37 M-33.96%
2003-12-31$NZ$68.7 M-33.72%
2002-12-31$NZ$0.10 B-47.73%
2001-12-31$NZ$0.19 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$146.41 B-430,218.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.99 B-61,761.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$33.84 B-99,535.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ$31.66 B-93,120.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$21.09 B-62,057.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$75.39 B-221,593.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.47 B-19,112.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$11.35 B-33,451.04%๐Ÿ‡บ๐Ÿ‡ธ USA